Assenagon Asset Management
GNMK

Assenagon Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Assenagon Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-378,001
Closed -$2.45M – 1158
2019
Q2 		$2.45M Sell
378,001
-398,191
-51% -$2.81M 0.02% 465
2019
Q1 		$5.5M Buy
776,192
+141,020
+22% +$929K 0.05% 289
2018
Q4 		$3.09M Buy
+635,172
New +$3.31M 0.04% 333

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Assenagon Asset Management's GNMK Position: Q3 2019 in Review

Assenagon Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2019, closing a stake of 378,001 shares — an estimated $2.45M sold.

Assenagon Asset Management first reported a position in GNMK in Q4 2018 and held it in 3 quarters. The position peaked at $5.5M in Q1 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q3 2019.

  • Assenagon Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q3 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 378,001 GenMark Diagnostics, Inc shares in Q3 2019, an estimated $2.45M.
  • Assenagon Asset Management first reported a position in GenMark Diagnostics, Inc in Q4 2018 and held it in 3 quarters.
  • Assenagon Asset Management's GenMark Diagnostics, Inc position peaked at $5.5M in Q1 2019.
  • 110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2019.

Based on Assenagon Asset Management's 13F filing for Q3 2019, filed 16 Oct 2019.